Merck KGaA (OTCMKTS:MKGAF – Get Free Report) passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $174.19 and traded as low as $166.98. Merck KGaA shares last traded at $167.55, with a volume of 93 shares traded.
Merck KGaA Stock Performance
The company has a debt-to-equity ratio of 0.28, a current ratio of 1.29 and a quick ratio of 0.82. The stock has a market cap of $21.65 billion, a PE ratio of 21.00 and a beta of 0.98. The firm has a 50 day moving average of $174.42 and a two-hundred day moving average of $167.81.
Merck KGaA (OTCMKTS:MKGAF – Get Free Report) last issued its earnings results on Wednesday, May 15th. The company reported $1.74 EPS for the quarter, missing analysts’ consensus estimates of $1.92 by ($0.18). Merck KGaA had a net margin of 13.09% and a return on equity of 11.61%. The business had revenue of $5.56 billion during the quarter. Research analysts predict that Merck KGaA will post 9.73 EPS for the current fiscal year.
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Featured Stories
- Five stocks we like better than Merck KGaA
- What is a Low P/E Ratio and What Does it Tell Investors?
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- MarketBeat Week in Review – 6/24 – 6/28
- What is a buyback in stocks? A comprehensive guide for investors
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.